Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000000582
JPRN-UMIN000000582Not yet recruitingPhase 4

Collaborative Trial of Fluvastatin on Atrial Fibrillation - CO-FAT study

CO-FAT study group0 sites300 target enrollmentStarted: January 31, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
300
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1) patients who underwent catheter ablation within 3 months 2) patients who underwent cardiac surgery within 1 month 3) patients with a history of cerebrovascular disorder or myocardial infarction within 1 month 4) patients with severe heart failure 5) patients with dialysis or severe renal dysfunction 6) patients with severe liver dysfunction 7) other patients who are judged to be inappropriate for the study by the investigator

Investigators

Sponsor
CO-FAT study group

Similar Trials

Recruiting
Phase 3
CATALYST TrialAtrial fibrillation
JPRN-jRCT2072220013Kozuma Ken120
Active, not recruiting
Not Applicable
Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection - NDChronic hepatitis C in HIV/HCV coinfectionMedDRA version: 9.1Level: LLTClassification code 10019744Term: Hepatitis C
EUCTR2006-006588-21-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
Completed
Phase 4
Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients TransplantGraft Vasculopathy
NCT00565474Novartis Pharmaceuticals84
Recruiting
Not Applicable
Catalyst Trial: Clinical trial of atrial fibrillation patients comparing left atrial appendage occlusion therapy to non-vitamin K antagonist oral anticoagulantsheart rhythm disorder10007521atrial fibrillation
NL-OMON54346St. Jude Medical26
Not yet recruiting
Not Applicable
A study on safety and efficacy of atrial fibrillation ablation using ThermoCoolTM SmartTouchTM Surround Flow catheter: comparison with ThermoCool TM SmartTouch TM (thermo cool smart touch) catheteratrial fibrillation
JPRN-UMIN000025570Hirosaki University Graduate School of Medicine60